Back to discover
Drug

Quetiapine

In clinical development
Emerging researchLate-stage development

Also known as Seroquel, Quetiapina, QUEtiapine Fumarate, Quetiapinum.

2
Research papers
10
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease

Clinical trial2026-08-01Primary completion · ClinicalTrials.gov

Effectiveness of Switching Antipsychotic Medications

Clinical trial2026-05-15Results posted · ClinicalTrials.gov

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Clinical trial2025-12-16Results expected Q1 2030 · ClinicalTrials.gov

Quetiapine for Bipolar Disorder and Alcohol Dependence

Clinical trial2025-07-25Results posted · ClinicalTrials.gov

Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.

Research2012-04-26European eating disorders review : the journal of the Eating Disorders Association

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Quetiapine
Aliases & brands
SeroquelQuetiapinaQUEtiapine FumarateQuetiapinum
RxNorm CUI
51272
ChEMBL ID
CHEMBL716
UNII
BGL0JSY5SI

Clinical trials

155 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
155
registered trials across all phases
LATEST COMPLETION 2024
10
Active studies
8
Recruiting
128
Late-stage (III+)
99
Completed
46
Discontinued
PHASE DISTRIBUTIONn = 155
Early Phase 12Phase 18Phase 1 / 22Phase 215Phase 2 / 36Phase 333Phase 471Phase N / A18

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20122013
Most influential

Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.

European eating disorders review : the journal of the Eating Disorders Association · 2012 · 29 cites
Recent papers

Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.

European eating disorders review : the journal of the Eating Disorders Association · 2012 · 29 cites
Journals, researchers & institutions
Top journals
  • Addiction biology1
  • European eating disorders review : the journal of the Eating Disorders Association1
Leading researchers
  • Comer SD1
  • Cooper ZD1
  • Foltin RW1
  • Haney M1
  • Hart CL1
  • Kaye W1
  • Klabunde M1
  • Powers PS1
Leading institutions
free-text, unnormalised
  • Health Sciences Center1
  • New York State Psychiatric Institute and Department of Psychiatry1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials